| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $170.4M | -1.0% | +1.5% |
| Cost of Revenue | $76.3M | +8.2% | -15.7% |
| Gross Profit | $94.1M | -7.3% | +21.6% |
| R&D Expense | $16.9M | +0.6% | +10.7% |
| SG&A Expense | $17.1M | -8.9% | +5.3% |
| Operating Income | $22.7M | -24.8% | +113.8% |
| Pre-tax Income | $25.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $187.9M | -37.0% | +32.0% |
| Short-term Investments | $19.2M | -75.6% | -81.6% |
| Accounts Receivable | $88.5M | +8.0% | -5.1% |
| Inventory | $148.0M | +5.0% | -23.0% |
| Current Assets | $441.1M | -26.4% | -18.4% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $117.8M | — | — |
| Investing Cash Flow | $67.9M | — | — |
| Financing Cash Flow | -$230.5M | — | — |
| -24.3% |
| +81.0% |
| Income Tax | $5.1M | -45.3% | +91.4% |
| Net Income | $20.5M | -16.2% | +78.6% |
| EPS (Basic) | $0.10 | -16.7% | +100.0% |
| EPS (Diluted) | $0.10 | -9.1% | +100.0% |
| $564.3M |
| -21.8% |
| -15.0% |
| Current Liabilities | $187.0M | -52.4% | +9.2% |
| Total Liabilities | $205.9M | -50.1% | +9.5% |
| Stockholders' Equity | $358.4M | +16.0% | -24.7% |